Renee M. Marshall, Ph.D. - Publications
Affiliations: | 2006 | Temple University, Philadelphia, PA, United States |
Area:
Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2007 | Salerno D, Hasham MG, Marshall R, Garriga J, Tsygankov AY, Graña X. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes. Gene. 405: 65-78. PMID 17949927 DOI: 10.1016/J.Gene.2007.09.010 | 0.464 | |||
2006 | Marshall RM, Grana X. Mechanisms controlling CDK9 activity. Frontiers in Bioscience : a Journal and Virtual Library. 11: 2598-613. PMID 16720337 DOI: 10.2741/1994 | 0.442 | |||
2006 | Salerno D, Hasham M, Marshall R, Garriga J, Tsygankov A, Graña X. Differential effects on HIV replication and T cell activation following direct inhibition of CDK9 or flavopiridol (FVP) treatment in primary peripheral blood lymphocytes Retrovirology. 3: 56. DOI: 10.1186/1742-4690-3-S1-P56 | 0.488 | |||
2005 | Marshall RM, Salerno D, Garriga J, Graña X. Cyclin T1 expression is regulated by multiple signaling pathways and mechanisms during activation of human peripheral blood lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 175: 6402-11. PMID 16272292 DOI: 10.4049/Jimmunol.175.10.6402 | 0.455 | |||
2003 | Garriga J, Bhattacharya S, Calbó J, Marshall RM, Truongcao M, Haines DS, Graña X. CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. Molecular and Cellular Biology. 23: 5165-73. PMID 12861003 DOI: 10.1128/Mcb.23.15.5165-5173.2003 | 0.407 | |||
Show low-probability matches. |